Mechanism of glutamine-mediated amelioration of lipopolysaccharide-induced IL-8 production in Caco-2 cells

Cytokine

Volumn 26, Issue 2, 2004, Pages 57-65

  Liboni, Kellym ^a   Li, Nan ^a   Neu, Josef ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Caco 2 cells; Gln; Glutamine; IL 8; Lipopolysaccharide; LPS; MAPK; Methionine sulfoximine; Mitogen activated protein kinase; MS; NF B; Nuclear factor kappa B; Signal transducer and activator of transcription 4; STAT 4

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GLUTAMATE AMMONIA LIGASE; GLUTAMINE; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; METHIONINE SULFOXIMINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT4 PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CELL STRAIN CACO 2; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYPOTHESIS; INCUBATION TIME; INFLAMMATION; INTESTINE EPITHELIUM; PRIORITY JOURNAL; PROTEIN BINDING; STATISTICAL SIGNIFICANCE; UPREGULATION;

CACO-2 CELLS; DNA-BINDING PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GLUTAMINE; HUMANS; IMIDAZOLES; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN ARRAY ANALYSIS; PROTEIN-TYROSINE KINASES; PYRIDINES; STAT4 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 1642634629     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2003.12.008     Document Type: Article

References (40)

1. Eckmann L., Jung H.C., Schurer-Maly C., Panja A., Morzycka-Wroblewska E., Kagnoff M.F. Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology. 105:1993;1689-1697.
2. Walker W.A. Role of nutrients and bacterial colonization in the development of intestinal host defense. J Pediatr Gastroenterol Nutr. 30:2000;S2-S7.
3. Baggiolini M. Chemokines in pathology and medicine. J Intern Med. 250:2001;91-104.
4. De Dooy J.J., Mahieu L.M., Van Bever H.P. The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr. 160:2001;457-463.
5. Grimble R.F. Symposium on "evidence-based nutrition", nutrition modulation of immune function. Proc Nutr Soc. 60:2001;389-397.
6. Muehlstedt S.G., Richardson C.J., West M.A., Lyte M., Rodriguez J.L. Cytokines and the pathogenesis of nosocomial pneumonia. Surgery. 130:2001.
7. Neu J., Auestad N., DeMarco V.G. Glutamine metabolism in the fetus and critically ill low birth weight neonate. Adv Pediatr. 49:2002.
8. Wischmeyer P.E., Lynch J., Liedel J., Wolfson R., Riehm J., Gottlieb L., et al. Glutamine administration reduces gram-negative bacteria in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med. 29:2001;2075-2080.
9. Houdijk A.P., Rijnsburger E.R., Jansen J., Wesdorp R.I., Weiss J.K., McCamish M.A., et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. [see comments] Lancet. 352:1998;772-776.
10. Ziegler T.R., Young L.S., Benfell K., Scheltinga M., Hortos K., Bye R., et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med. 116:1992;821-828.
11. Wischmeyer P.E., Kahana M., Wolfson R., Ren H., Musch M.M., Chang E.B. Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. Shock. 16:2001;393-402.
12. Coeffier M., Miralles-Barrachina O., Le Pessot F., Lalaude O., Daveau M., Lavoinne A., et al. Influence of glutamine on cytokine production by human gut in vitro. Cytokine. 13:2001;148-154.
13. Fukatsu K., Kudsk K.A., Zarzaur B.L., Wu Y., Hanna M.K., DeWitt R.C. TPN decreases IL-4 and IL-10 mRNA expression in lipopolysaccharide stimulated intestinal lamina propria cells but glutamine supplementation preserves the expression. Shock. 15:2001;318-322.
14. Jobin C., Sartor R.B. The I B/NF-B system: a key determinant of mucosal inflammation and protection. Am J Physiol Cell Physiol. 278:2000;C451-C462.
15. Lawrence T., Gilroy D.W., Colville-Nash P.R., Willoughby D.A. Possible new role for NF-B in the resolution of inflammation. Nat Med. 7:2001;1291-1297.
16. Frost J.A., Swantek J.L., Stippec S., Yin M.J., Gaynor R., Cobb M.H. Stimulation of NF-B activity by multiple signaling pathways requires PAK1. J Biol Chem. 276:2000;19693-19699.
17. Huang Y., Li N., Liboni K., Neu J. Glutamine decreases lipopolysaccharide-induced IL-8 production in Caco-2 cells through a non-NF-kappaB p50 mechanism. Cytokine. 22:2003;77-83.
18. Raingeaud J., Gupta S., Rogers J.S., Dickens M., Han J., Ulevitch R.J., et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem. 270:1995;7420-7426.
19. Briske-Anderson M.J., Finley J.W., Newman S.M. The influence of culture time and passage number on the morphological and physiological development of Caco-2 cells. Proc Soc Exp Biol Med. 214:1997;248-257.
20. Mariadason J.M., Bordonaro M., Aslam F., Shi L., Kuraguchi M., Velcich A., et al. Down-regulation of beta-catenin TCF signaling is linked to colonic epithelial cell differentiation. Cancer Res. 61:2001;3465-3471.
21. Fusunyan R.D., Quinn J.J., Fujimoto M., MacDermott R.P., Sanderson I.R. Butyrate switches the pattern of chemokine secretion by intestinal epithelial cells through histone acetylation. Mol Med. 5:1999;631-640.
22. Ogle C.K., Guo X.L., Hasselgren P.O., Ogle J.D., Alexander J.W. The gut as a source of inflammatory cytokines after stimulation with endotoxin. Eur J Surg. 163:1997;45-51.
23. Haller D., Bode C., Hammes W.P., Pfeifer A.M.A., Schiffrin E.J., Blum S. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut. 47:2000;79-87.
24. Schuerer-Maly C.C., Eckmann L., Kagnoff M.F., Falco M.T., Maly F.E. Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology. 81:1994;85-91.
25. Nanthakumar N.N., Fusunyan R.D., Sanderson I., Walker W.A. Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci U S A. 97:2000;6043-6048.
26. Murata Y., Ishiguro Y., Itoh J., Munakata A., Yoshida Y. The role of pro-inflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis. Gastroenterol Clin North Am J. 30:(Suppl 8):1995;56-60.
27. Coeffier M., Marion R., Leplingard A., Lerebours E., Ducrotte P., Dechelotte P. Glutamine decreased interleukin-8 and interleukin-6 but not nitric oxide and prostaglandins E2 production by human gut in vitro. Cytokine. 18:2002.
28. de Beaux A.C., O'Riordain M.G., Ross J.A., Jodozi L., Carter D.C., Fearon K.C. Glutamine-supplemented total parenteral nutrition reduces blood mononuclear cell interleukin-8 release in severe acute pancreatitis. Nutrition. 14:1998;261-265.
29. Ameho C.K., Adjei A.A., Harrison E.K., Takeshita K., Morioka T., Arakaki Y., et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut. 41:1997;487-493.
30. Weiss M.D., DeMarco V., Strauss D.M., Samuelson D.A., Lane M.E., Neu J. Glutamine synthetase: a key enzyme for intestinal epithelial differentiation? J Parenter Enteral Nutr. 23:1999;140-146.
31. Le Bacquer O., Laboisse C., Darmaun D. Glutamine preserves protein synthesis and paracellular permeability in Caco-2 cells submitted to "luminal fasting" Am J Physiol Gastrointest Liver Physiol. 285:2003;G128-G136.
32. Lacey J.M., Wilmore D.W. Is glutamine a conditionally essential amino acid? Nutr Rev. 48:1990;297-309.
33. Neu J., Roig J.C., Meetze W.H., Veerman M., Carter C., Millsaps M., et al. Enteral glutamine supplementation for very low birth weight infants decreases morbidity. J Pediatr. 131:1997;691-699.
34. Rhoads J.M. Glutamine signaling in intestinal cells. J Parenter Enteral Nutr. 1999;S38-S40.
35. Rhoads J.M., Argenzio R.A., Chen W., Rippe R.A., Westwick J.K., Cox A.D., et al. L-glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases. Am J Physiol. 272:1997.
36. Subramaniam P.S., Torres B.A., Johnson H.M. So many ligands, so few transcription factors: a new paradigm for signaling through the STAT transcription factors. Cytokine. 15:2001;175-187.
37. Halpern M.D., Holubec H., Dominguez J.A., Williams C.S., Meza Y.G., McWilliam D.L., et al. Up-regulation of IL-18 and IL-12 in the ileum of neonatal rats with necrotizing enterocolitis. Pediatr Res. 51:2002;733-739.
38. Ethuin F., Delarche C., Benslama S., Gougerot-Pocidalo M.A., Jacob L., Chollet-Martin S. Interleukin-12 increases interleukin 8 production and release by human polymorphonuclear neutrophils. J Leukoc Biol. 70:2001;439-446.
39. Wirtz S., Finotto S., Kanzler S., Lohse A.W., Blessing M., Lehr H.A., et al. Cutting edge: chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF- plus IFN-gamma-producing CD4+ T cells that respond to bacterial antigens. J Immunol. 162:1999;1885-1888.
40. Matsukawa A., Kaplan M.H., Hogaboam C.M., Lukacsa N.W., Kunkel S.L. Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis. J Exp Med. 103:2001;679-688.